IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,077,658 | -13.8% | 226,821 | -19.3% | 0.00% | -25.0% |
Q2 2023 | $11,689,427 | -6.5% | 281,131 | -6.6% | 0.00% | -20.0% |
Q4 2022 | $12,497,748 | -30.7% | 301,078 | -21.9% | 0.01% | -37.5% |
Q3 2022 | $18,022,000 | +95.5% | 385,729 | +66.3% | 0.01% | +100.0% |
Q2 2022 | $9,220,000 | -3.8% | 231,992 | -13.6% | 0.00% | -20.0% |
Q1 2022 | $9,583,000 | +33.7% | 268,497 | +17.0% | 0.01% | +25.0% |
Q4 2021 | $7,167,000 | -15.6% | 229,407 | -8.1% | 0.00% | 0.0% |
Q3 2021 | $8,493,000 | -43.8% | 249,704 | -34.5% | 0.00% | -50.0% |
Q2 2021 | $15,111,000 | +9.9% | 381,485 | +18.4% | 0.01% | -11.1% |
Q1 2021 | $13,755,000 | -36.3% | 322,230 | -7.3% | 0.01% | -35.7% |
Q4 2020 | $21,589,000 | +42.6% | 347,644 | +4.0% | 0.01% | +7.7% |
Q3 2020 | $15,137,000 | -35.2% | 334,172 | -13.6% | 0.01% | -38.1% |
Q2 2020 | $23,370,000 | +40.1% | 386,670 | +13.6% | 0.02% | +10.5% |
Q1 2020 | $16,684,000 | +769.9% | 340,444 | +972.4% | 0.02% | +1800.0% |
Q4 2019 | $1,918,000 | +24.6% | 31,746 | +23.6% | 0.00% | 0.0% |
Q3 2019 | $1,539,000 | -3.5% | 25,688 | +3.5% | 0.00% | 0.0% |
Q2 2019 | $1,595,000 | -40.7% | 24,826 | -25.1% | 0.00% | -50.0% |
Q1 2019 | $2,689,000 | +39.5% | 33,136 | -7.1% | 0.00% | 0.0% |
Q4 2018 | $1,928,000 | +104.7% | 35,651 | +95.2% | 0.00% | +100.0% |
Q3 2018 | $942,000 | +19.4% | 18,265 | -3.6% | 0.00% | 0.0% |
Q2 2018 | $789,000 | +1.3% | 18,950 | +7.3% | 0.00% | 0.0% |
Q1 2018 | $779,000 | -2.1% | 17,662 | +11.8% | 0.00% | 0.0% |
Q4 2017 | $796,000 | -39.2% | 15,801 | -38.8% | 0.00% | 0.0% |
Q3 2017 | $1,309,000 | +407.4% | 25,818 | +409.1% | 0.00% | – |
Q2 2017 | $258,000 | +6.6% | 5,071 | -15.4% | 0.00% | – |
Q1 2017 | $242,000 | -22.7% | 5,997 | -16.0% | 0.00% | – |
Q4 2016 | $313,000 | +63.9% | 7,142 | +36.8% | 0.00% | – |
Q3 2016 | $191,000 | -51.5% | 5,222 | -69.1% | 0.00% | – |
Q2 2016 | $394,000 | -42.2% | 16,893 | +0.4% | 0.00% | -100.0% |
Q1 2016 | $682,000 | -35.7% | 16,825 | -1.7% | 0.00% | 0.0% |
Q4 2015 | $1,060,000 | – | 17,114 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |